Let's not forget about Abbott Laboratories' impressive streak of 52 consecutive annual dividend increases, which also makes ...
Piper Sandler initiated coverage on Abbott Laboratories (NYSE:ABT) with an "overweight" rating and a price target of $131 per ...
Abbott's strong innovation pipeline, including advancements in CGM systems, supports its market share gains and growth ...
NEW BEAUNFELS, Texas - Governor Greg Abbott delivered remarks at an event presenting the keys for a brand new, specialty ...
Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...
3d
Adam Maeder, an analyst from Piper Sandler, has initiated a new Buy rating on Abbott Laboratories (ABT). Adam Maeder has given his Buy rating ...
In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report), ...
A new survey of epidemiology and infectious diseases experts evaluate how prepared we are for disease outbreaks and overall ...
If you’re looking for the most unique gift of all, Abbott Lyon’s new personalised fingerprint jewellery collection is the ...
Get £500 worth of Abbott Lyon jewellery for £299 in personalisable advent calendar. With gold and silver options available ...
If you're looking for a truly unique jewellery gift this Christmas, then Stacey Solomon's go-to brand Abbott Lyon's new ...
Abbott Laboratories' diabetes care segment recently added new products to its lineup. It should remain one of the company's key growth drivers over the long run. There are other good reasons to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback